Our study not only identified a novel role of IL-1β in the pathophysiology of endotoxemia-elicited neuroinflammation but also suggested a new strategy for developing potential therapies for neurodegenerative diseases. The gene discussed is IL1B; the disease is neurodegenerative disease.